Know exactly who you're buying from.

Polaris runs COAs per product rather than a single page — each listing carries its own Chromate Analytics or Janoshik report. Eleven tested peptides average 99.4% purity, with no results below 98.36%. On top of that, Finnrick endotoxin records exist for multiple products, adding a second independent verification layer that most vendors at this score level don't have. Ownership is publicly disclosed. The COA archive requires a free account login to browse, which is a minor friction point but not unusual for a members-model vendor. Physical address is not on the public site. The testing documentation here — named labs, batch-specific COAs, independent endotoxin verification — is among the most comprehensive we review. The missing physical address is the one remaining accountability gap in an otherwise strong file.

Orbitrex has a near-spotless purity record from seven Finnrick-verified tests: 99.8–99.9% across all results, with no test below 99.8%. Batch-specific COAs are issued, methodology is documented, and a physical address is on file. Contact information is absent, and ownership is not disclosed — two gaps in the accountability profile. The testing evidence is consistent enough that it crosses into a pattern rather than a lucky sample: seven independent tests with a 0.1% variance range is an unusually tight result set. The open items are the company identity gaps. Until contact information and ownership are published, buyers are transacting with a well-tested but partially anonymous operation.

Bulk Peptide Supply is one of the more transparent operations in this space: named ownership, a verified physical address, and seven products covered by Finnrick-verified independent testing. Average purity across those seven tests is 99.4%, with the lowest result a retatrutide batch at 96.8% — the only test below 98%. Two Finnrick labs are used across the catalog. No contact information is published, which is a gap given the otherwise clean identity record. Coverage is thin relative to catalog size — seven independently verified products across a range that runs wider than that. The core testing infrastructure is legitimate and the business accountability markers are in place. The contact information gap and thin coverage are the two areas that need to close before this vendor ranks higher.